Press / Medias
Cornell patent deal helps LNC ramp-up microbiome therapeutics strategy
Dec 17, 2018
A new patent licencing deal between Cornell and LNC Therapeutics will help the French biotech become the ‘must have’ partner for research and product development relating to the Christensenella strain, says the company’s CEO.
Clic here to read the full article
In the same category
Press / Medias
EMA & FDA Apply a Similar Mindset When Providing Scientific Advice For Live Biotherapeutic...
Sep 13, 2021
more +
Press / Medias
Press / Medias